Correlation Between NYSE Composite and Phoenix Biotech
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Phoenix Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Phoenix Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Phoenix Biotech Acquisition, you can compare the effects of market volatilities on NYSE Composite and Phoenix Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Phoenix Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Phoenix Biotech.
Diversification Opportunities for NYSE Composite and Phoenix Biotech
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between NYSE and Phoenix is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Phoenix Biotech Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phoenix Biotech Acqu and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Phoenix Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phoenix Biotech Acqu has no effect on the direction of NYSE Composite i.e., NYSE Composite and Phoenix Biotech go up and down completely randomly.
Pair Corralation between NYSE Composite and Phoenix Biotech
Assuming the 90 days trading horizon NYSE Composite is expected to generate 1.6 times more return on investment than Phoenix Biotech. However, NYSE Composite is 1.6 times more volatile than Phoenix Biotech Acquisition. It trades about 0.07 of its potential returns per unit of risk. Phoenix Biotech Acquisition is currently generating about 0.1 per unit of risk. If you would invest 1,518,431 in NYSE Composite on September 20, 2024 and sell it today you would earn a total of 380,265 from holding NYSE Composite or generate 25.04% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 28.28% |
Values | Daily Returns |
NYSE Composite vs. Phoenix Biotech Acquisition
Performance |
Timeline |
NYSE Composite and Phoenix Biotech Volatility Contrast
Predicted Return Density |
Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Phoenix Biotech Acquisition
Pair trading matchups for Phoenix Biotech
Pair Trading with NYSE Composite and Phoenix Biotech
The main advantage of trading using opposite NYSE Composite and Phoenix Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Phoenix Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phoenix Biotech will offset losses from the drop in Phoenix Biotech's long position.NYSE Composite vs. Relx PLC ADR | NYSE Composite vs. Century Aluminum | NYSE Composite vs. Udemy Inc | NYSE Composite vs. Blue Moon Metals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Global Correlations Find global opportunities by holding instruments from different markets | |
CEOs Directory Screen CEOs from public companies around the world | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |